Our study also proved that CXCR4 was an oncogene under the regulation of ERβ/circ-TMX4/miR-622 signaling to promote lung cancer progression, thus our work established the foundation to target this signaling for developing new drugs for the better treatment of lung cancer. This evidence concerns the gene ESR2 and lung cancer.